Breaking

Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill
State-level AI rules survive — for now — as Senate sinks moratorium despite White House pressure
DAVID MARCUS: Trump’s aggression toward Venezuela a warning to Putin
Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60
Copper Quest Closes $1,927,000 Private Placement
NioCorp Acquires FEA Materials to Build US Scandium Supply Chain
EXCLUSIVE: Charlie Kirk’s final book battles the ‘machine of modern life,’ urges a return to the Sabbath
Trump taps new architect to reshape White House as $300M ballroom build accelerates

Business
Politics
Investing
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60

December 6, 2025

Copper Quest Closes $1,927,000 Private Placement

December 6, 2025

NioCorp Acquires FEA Materials to Build US Scandium Supply Chain

December 6, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,183)
- Investing (4,413)
- Politics (5,961)
- World (4,215)

Disclaimer: MicroStocksSecrets.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 microstockssecrets.com | All Rights Reserved

Top

Business
Politics
Investing
World

Type above and press Enter to search. Press Esc to cancel.